HOME >> BIOLOGY >> NEWS
Chest compression device outperforms manual CPR

A battery-operated compression belt buckled around the chest restores blood flow better than manual chest compressions and conventional CPR, according to a Johns Hopkins-led animal study.

The device, which resembles an eight-inch wide seat belt, is buckled around the chest, tightened and motorized. Once switched on, it contracts against the chest, stimulating blood flow.

Researchers who tested the device on 20 pigs in cardiac arrest found that it restored blood flow four times better than manual compressions and returned the hearts to pre-arrest condition. Results of the study, supported by Revivant Corp., are to be presented Nov. 19 at the American Heart Association's 75th annual Scientific Sessions in Chicago.

"The key to restoring viability is to wash out the waste and move oxygenated blood to the vital organs," says Henry R. Halperin, M.D., lead author of the study and professor of medicine and biomedical engineering at Hopkins. "The belt can compress a greater area of the chest than manual compressions, so it restores more blood flow than manual CPR. Wherever a health care professional would do manual CPR, a device like this could be better for the patient."

Researchers induced ventricular fibrillation, an electrical abnormality in the heart that precedes cardiac arrest, in the pigs. They then performed both manual cardiopulmonary resuscitation and CPR using the belt device, in random order, and measured blood pressure and flow before and after injecting the pigs with epinephrine, a hormone that constricts small blood vessels.

About 350,000 people each year suffer sudden cardiac arrest, 95 percent of whom die; most require defibrillation. Defibrillators are most effective if used within the first two minutes of arrest, Halperin says, but most attacks occur at home. It can take an average of six to eight minutes for paramedics to arrive, he says, and defibrillation is often unsuccessful at th
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
19-Nov-2002


Page: 1 2

Related biology news :

1. Chestnut trees to spread across landscape again, says Purdue scientist
2. Chestnuts used chemicals to dominate southern Appalachian forests
3. Can exercise before diving prevent decompression sickness?
4. Decompression is a gas
5. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
6. University of Pittsburgh medical center among first to implant heart assist device
7. University of Pittsburgh receives NIH funding to develop heart assist device for infants
8. New database aids medical device exporters
9. Ancient Greeks help scientists build environmentally friendly nano devices
10. Tanning devices - Fast track to skin cancer?
11. New device can help defend against novel biological agents

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chest compression device outperforms manual CPR

(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
(Date:10/16/2014)... on the human body. Battles are won, lost ... cancer, this stalemate—known as tumor dormancy—can last up ... phenomena that is poorly understood. , A ... Salvatore Torquato, a Professor of Chemistry at Princeton ... dormancy and the switch to a malignant state. ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2
(Date:10/22/2014)... , Oct. 22, 2014 New test ... the in vitro diagnostic (IVD) test industry, especially as ... healthcare market researcher listed more than 25 testing innovations ... be the future of IVD products. Kalorama details the new ... The Worldwide Market for In Vitro Diagnostic Tests ...
(Date:10/22/2014)... The North American crystal oscillator market report defines and ... forecast of revenue. This market was valued at $531.4 ... million by 2018, at a CAGR of 3.3% from ... the North American crystal oscillator market report, to get ... provides a glimpse of the segmentation of the market, ...
(Date:10/22/2014)... San Diego, CA (PRWEB) October 22, 2014 ... laboratory balances from Sartorius, A & D Weighing, ... Sartorius CPA Semi-Micro Balance . The Sartorius ... looking for an affordable high-quality, precise, and user-friendly ... in manufacturing of laboratory equipment, their laboratory balances ...
(Date:10/22/2014)... --  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... and diseases, announced today that the U.S. Patent and ... a composition of matter patent application that covers the ... This is Synthetic Biologics, first allowed patent application directly ... the Company,s extensive C. difficile patent estate. ...
Breaking Biology Technology:Report: Radical New IVD Test Approaches Key To Growth 2Report: Radical New IVD Test Approaches Key To Growth 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: